Angiodynamics (ANGO) Net Income (2010 - 2026)

Angiodynamics (ANGO) has reported Net Income for 17 consecutive years, with -$11.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Income fell 88.51% year-over-year to -$11.4 million; the trailing twelve-month figure through May 2026 stood at -$36.7 million (down 8.09% YoY), and the FY2026 full-year result was -$36.7 million, down 8.09% from the prior year.
• Net Income fell to -$11.4 million in Q2 2026 per ANGO's latest filing, from -$8.1 million in the prior quarter.
• Across five years, Net Income topped out at $45.9 million in Q3 2023 and bottomed at -$187.7 million in Q1 2024.
• Historically, Net Income has averaged -$17.7 million across 5 years, with a median of -$10.1 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Net Income surged 452.85% in 2023, then tumbled 1879.29% in 2024.
• Over 5 years, Net Income stood at -$8.5 million in 2022, then plunged by 242.3% to -$29.0 million in 2023, then soared by 63.03% to -$10.7 million in 2024, then surged by 40.86% to -$6.4 million in 2025, then slumped by 79.61% to -$11.4 million in 2026.
• According to Business Quant data, Net Income over the past three periods registered -$11.4 million, -$8.1 million, and -$6.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.